In a new analysis of Phase 2 and 3 anifrolumab (Saphnelo®) clinical trial data, researchers found that the SLE Disease ...
National Lupus Advocacy Summit brings powerful voices to Capitol Hill to advocate for all Americans living with lupus. Hundreds of lupus advocates from 42 states gathered in Washi ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s supplemental Biologics License Application for Gazyva® (obinutuzumab) for adults with systemic lupus erythematosus (SLE). The ...
If you have a parent, sibling, or child diagnosed with lupus — but you do not have lupus yourself — you may be eligible to participate in CARE Lupus. Lupus has long been treated after symptoms begin - ...
May is Lupus Awareness Month! Rally your family, friends and community to raise funds and awareness of the invisible physical, emotional and financial impact of lupus. Help us continue to advocate, ...
The Next Chapter in Lupus Care: Phase III & FDA Fast Track Clinical Trials, Therapies & What’s Ahead
This webinar connects people living with lupus, their care partners, and the broader community directly to Phase III clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results